Evidence map›Paper›PMID 23382707›Full record

ArticlePLoS genetics2013

Genetics of ribosomal proteins: "curiouser and curiouser".

Tamara Terzian, Neil Box

Abstract readComment
In one paragraph

Article in PLoS genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Mouse Models of Rare Craniofacial Disorders.Current topics in developmental biology · 2015
    Review
  9. Article
  10. Article
  11. Article
  12. Ribosomopathies: mechanisms of disease.Clinical medicine insights. Blood disorders · 2014
    Review
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Tamara TerzianUniversity of Colorado Denver, Dermatology Department and Center for Regenerative and Medicine and Stem Cell Biology, Aurora, Colorado, United States of America. Tamara.Terzian@ucdenver.edu
Neil Box

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Transgenic and Gene Targeting CoreP30AR057212 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI KOCH, PETER J. · 2009 to 2018
$6.2M
Targeting p53-Dependent Repigmentation in VitiligoK01AR063203 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI TERZIAN, TAMARA G · 2012 to 2016
$503k
NCI NIH HHS P30 CA046934NCI NIH HHS P30-CA046934NIAMS NIH HHS K01 AR063203NIAMS NIH HHS K01-AR063203NIAMS NIH HHS P30 AR057212NIAMS NIH HHS P30-AR057212
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anemia, Diamond-BlackfanCentral Nervous SystemAnimalsHumansMorphogenesisRibosomal ProteinsRibosomal Proteinsribosomal protein S7

Identifiers

PMID23382707
PMCPMC3561088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.